271 – 280 of 335
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Clinical outcomes and resource utilization associated with haemophilia care in Europe
- Contribution to journal › Article
-
Mark
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
- Contribution to journal › Article
-
Mark
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
- Contribution to journal › Article
-
Mark
Unresolved issues in prophylaxis
- Contribution to journal › Article
-
Mark
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.
- Contribution to journal › Article
-
Mark
The prognostic value of global haemostatic tests in the intensive care unit setting.
- Contribution to journal › Article
- 2001
-
Mark
Therapeutic choices for patients with hemophilia and high-titer inhibitors
- Contribution to journal › Article
-
Mark
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis
- Contribution to journal › Article
-
Mark
Anti- and procoagulant activities in factor VII-deficient subjects
- Contribution to journal › Article
-
Mark
The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients
- Contribution to journal › Article